𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of diurnal effect on vancomycin disposition in infected patients

✍ Scribed by L. S. Wang; M. S. Lin; J. D. Huang


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
249 KB
Volume
79
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


High prevalence of TT virus (TTV) infect
✍ Forns, Xavier; Hegerich, Patricia; Darnell, Alejandro; Emerson, Suzanne U.; Purc πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

Recently, a novel DNA virus, TT virus (TTV), was identified in patients with post-transfusion non-A-G hepatitis. We analyzed the prevalence and clinical implications of TTV infection in a cohort of 96 Spanish patients on long-term hemodialysis. TTV DNA was detected by nested PCR in 51 (53%) of 96 pa

The effects of non-steroidal anti-inflam
✍ M. Perwaiz Iqbal; Javed A. Baig; Azra A. Ali; Sarfaraz K. Niazi; N. Mehboobali; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 3 views

We have studied the pharmacokinetics of methotrexate in patients with rheumatoid arthritis concurrently taking the most commonly used non-steroidal anti-inflammatory drugs (NSAIDs), aspirin, diclofenac, naproxen, indomethacin, and ibuprofen. The area under the curve, the total systemic clearance, t

No pol mutation is associated independen
✍ Nicola Gianotti; Laura Galli; Maurizio Zazzi; Valeria Ghisetti; Stefano Bonora; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 233 KB πŸ‘ 2 views

## Abstract An investigation was undertaken to determine whether specific __pol__ mutations hinder long‐term immune recovery regardless of virological response. In total, 826 patients with >50 HIV RNA copies/ml, who underwent genotypic resistance testing between 1 January 2000 and 31 December 2003

Nonsteroidal antiinflammatory drug thera
✍ P. Lavie; M. Nahir; M. Lorber; Y. Scharf πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 496 KB πŸ‘ 2 views

Thirteen patients with rheumatoid arthritis (mean & SD age 55.8 f 10.5 years) received 20 mg of tenoxicam daily for 90 days following a 3-7-day "washout" period and 4 days of placebo treatment. Clinical evaluations were conducted at the end of the washout period and at monthly intervals thereafter.